Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus - PubMed (original) (raw)
Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus
S M Lechner et al. Brain Res. 1999.
Abstract
The stress-related neurohormone, corticotropin-releasing factor (CRF), also acts as a neurotransmitter to activate the brain noradrenergic nucleus, locus coeruleus (LC). Previous electrophysiological findings demonstrating that tonic CRF secretion in the LC is increased in adrenalectomized rats suggest that activity of certain CRF afferents to the LC is under inhibitory regulation by endogenous corticosteroids. The present study was designed to identify putative CRF afferents to the LC that may be regulated by glucocorticoids. Retrograde tract tracing from the rat LC and pericoerulear regions was combined with immunohistochemistry to visualize CRF and glucocorticoid receptors in the same sections of rat brain. The retrograde tracer, wheat germ agglutinin conjugated to horseradish peroxidase coupled to gold (WGA-Au-HRP) was injected into either the nucleus LC or the rostrolateral pericoerulear region (peri-LC), where CRF-immunoreactive terminals have been demonstrated to synapse with LC dendrites. Sections were processed to visualize the tracer, as well as CRF- and glucocorticoid receptor-immunoreactivity. Following injections of WGA-Au-HRP into the nuclear LC, triple labeled neurons were observed primarily in Barrington's nucleus, where 74+/-4% of retrogradely labeled CRF-immunoreactive neurons colocalized glucocorticoid receptor immunoreactivity. In contrast, injections that incorporated the rostrolateral peri-LC retrogradely labeled numerous neurons that were immunoreactive for both CRF and glucocorticoid receptors in the central nucleus of the amygdala. Thus, 94+/-2% of the retrogradely labeled CRF-immunoreactive neurons in the central nucleus of the amygdala colocalized glucocorticoid receptor immunoreactivity. Additionally, triple labeled neurons were observed in the bed nucleus of the stria terminalis following WGA-Au-HRP injections that incorporated the rostrolateral peri-LC. The present results implicate Barrington's nucleus, the central nucleus of the amygdala and the bed nucleus of the stria terminalis as glucocorticoid-sensitive sources of CRF that can influence the LC-noradrenergic system. Alterations in glucocorticoid levels or glucocorticoid receptor function would be predicted to affect the impact of these specific CRF systems on LC activity.
Copyright 1999 Elsevier Science B.V.
Similar articles
- Evidence for divergent projections to the brain noradrenergic system and the spinal parasympathetic system from Barrington's nucleus.
Valentino RJ, Chen S, Zhu Y, Aston-Jones G. Valentino RJ, et al. Brain Res. 1996 Sep 2;732(1-2):1-15. doi: 10.1016/0006-8993(96)00482-9. Brain Res. 1996. PMID: 8891263 - Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response.
Van Bockstaele EJ, Colago EE, Valentino RJ. Van Bockstaele EJ, et al. J Neuroendocrinol. 1998 Oct;10(10):743-57. doi: 10.1046/j.1365-2826.1998.00254.x. J Neuroendocrinol. 1998. PMID: 9792326 - A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents.
Van Bockstaele EJ, Peoples J, Valentino RJ. Van Bockstaele EJ, et al. Biol Psychiatry. 1999 Nov 15;46(10):1352-63. doi: 10.1016/s0006-3223(99)00213-9. Biol Psychiatry. 1999. PMID: 10578450 - Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.
Lehnert H, Schulz C, Dieterich K. Lehnert H, et al. Neurochem Res. 1998 Aug;23(8):1039-52. doi: 10.1023/a:1020751817723. Neurochem Res. 1998. PMID: 9704593 Review. - Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress.
Gray TS. Gray TS. Ann N Y Acad Sci. 1993 Oct 29;697:53-60. doi: 10.1111/j.1749-6632.1993.tb49922.x. Ann N Y Acad Sci. 1993. PMID: 8257022 Review.
Cited by
- The brain's supply and demand in obesity.
Kubera B, Hubold C, Zug S, Wischnath H, Wilhelm I, Hallschmid M, Entringer S, Langemann D, Peters A. Kubera B, et al. Front Neuroenergetics. 2012 Mar 8;4:4. doi: 10.3389/fnene.2012.00004. eCollection 2012 Jan 10. Front Neuroenergetics. 2012. PMID: 22408618 Free PMC article. - A circadian rhythm in the expression of PERIOD2 protein reveals a novel SCN-controlled oscillator in the oval nucleus of the bed nucleus of the stria terminalis.
Amir S, Lamont EW, Robinson B, Stewart J. Amir S, et al. J Neurosci. 2004 Jan 28;24(4):781-90. doi: 10.1523/JNEUROSCI.4488-03.2004. J Neurosci. 2004. PMID: 14749422 Free PMC article. - Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.
Davis M, Walker DL, Miles L, Grillon C. Davis M, et al. Neuropsychopharmacology. 2010 Jan;35(1):105-35. doi: 10.1038/npp.2009.109. Neuropsychopharmacology. 2010. PMID: 19693004 Free PMC article. Review. - The central amygdala as an integrative hub for anxiety and alcohol use disorders.
Gilpin NW, Herman MA, Roberto M. Gilpin NW, et al. Biol Psychiatry. 2015 May 15;77(10):859-69. doi: 10.1016/j.biopsych.2014.09.008. Epub 2014 Sep 22. Biol Psychiatry. 2015. PMID: 25433901 Free PMC article. Review. - Early-life stress disrupts attachment learning: the role of amygdala corticosterone, locus ceruleus corticotropin releasing hormone, and olfactory bulb norepinephrine.
Moriceau S, Shionoya K, Jakubs K, Sullivan RM. Moriceau S, et al. J Neurosci. 2009 Dec 16;29(50):15745-55. doi: 10.1523/JNEUROSCI.4106-09.2009. J Neurosci. 2009. PMID: 20016090 Free PMC article.